JPRN-UMIN000021695
Completed
N/A
PREVENTion of Contrast-Induced Nephropathy after Cardiovascular catheterization and intervention by high dose statin therapy in Japan - PREVENTion of Contrast-Induced Nephropathy after Cardiovascular catheterization and intervention by high dose statin therapy in Japan (Prevent CINC-J study)
ara Medical University0 sites420 target enrollmentMay 9, 2016
Overview
- Phase
- N/A
- Intervention
- Not specified
- Conditions
- Coronary artery disease with dyslipidemia and chronic kidney disease
- Sponsor
- ara Medical University
- Enrollment
- 420
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •1\. Contraindication to statin treatment 2\. Contraindication to contrast medium 3\. Treatment with fibrate 4\. Treatment with cyclosporine 5\. Severe liver dysfunction (acute hepatitis, liver cirrhosis, liver cancer, jaundice, GOT or GPT\>\=100IU/l) 6\. Severe renal dysfunction (acute renal failure, maintenance dialysis, serum creatinine\>\=3mg/dl) 7\. CPK\>\=350IU/L 8\. Patients receiving high dose statin (atorvastatine;\>\=15mg/day,rosvastatin;\>\=7\.5mg/day,pitavastatin;\>\=3mg/day) before enrollment 9\. Familial hypercholesterolemia 10\. Nephrotic syndrome 11\. Contrast medium administration within the previous 10 days 12\. Pregnant, becoming pregnant, breast feeding 13\. Inadequate to this study
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
N/A
Prevention of Contrast Induced Nephropathy after Endovascular Therapy combined with Carbon Dioxide-digital subtraction angiography in Patients With Ilio-Femoropopliteal artery diseasesperipheral artery diseaseJPRN-UMIN000011988Sakakibara Heart Institute100
Completed
Phase 3
prevention of kidney injury caused by contrast media during angioplasty/graphy by adminstration of sodium potassium citrate solutiocontrast induced nephropathy.Drug- and heavy-metal-induced tubulo-interstitial and tubular conditionsIRCT2015050322065N1Vice chancellor for research, Ahvaz Jundishapur University of Medical Sciences190
Completed
Phase 4
Preventing contrAst induced Nephropathy after TranscathEter aortic valve Replacementaortic stenosiskidney injury1004697310029149NL-OMON43053Sint Antonius Ziekenhuis200
Recruiting
N/A
the Prevention of Contrast-Induced Nephropathy by Atrial Natriuretic Peptide in Endovascular Aneurysm Repair.patients underwent endovascular aneurysm repairJPRN-UMIN000003909Jikei University, School of Medicine Department of Surgery, Vascular Surgery50
Not Yet Recruiting
N/A
Protection from Contrast Induced Nephropathy with Remote Ischemic ConditioningSubjects with CKD (eGFR <60ml/min/m2) undergoing elective CAG and PCIJPRN-UMIN000011264Osaka City University270